Send us a text

In this episode, we sit down with Dr. Ari Baratz to discuss recurrent pregnancy loss (RPL). October is Pregnancy & Infant Loss Awareness Month. Dr. Baratz discusses the incidence of RPL, its causes, the emotional and medical impact on patients, and what RPL means for your family-building plans.

At Fertility Matters Canada, our hearts are with everyone who has experienced the profound loss of a pregnancy or infant. We honor the strength, resilience, and love that carry you forward, and we're here to support you every step of the way.

About Dr. Ari Baratz

Dr. Ari Baratz has been dedicated to women’s health and reproductive medicine for over twenty years. He is one of a select few physicians in Canada with the accreditation and advanced level of training required for caring for people with infertility and recurrent miscarriages.

Upon joining CReATe, Dr. Baratz assumed a faculty position in the Department of Obstetrics & Gynecology, University of Toronto. Dr. Baratz has played an integral role in the Department of Gynecology at the New Women’s College Hospital, University of Toronto. He is a leader in Ambulatory Gynecology and Surgical education and has mentored many students, residents, and fellows in reproductive medicine.

Through CReATe, Women’s College Hospital, and the University of Toronto, Dr. Baratz continues his research in medical education and several aspects of clinical infertility and reproductive endocrinology.

Focused on providing ‘patient-centered’ fertility care, Dr. Baratz’s clinical interests include providing all forms of assisted reproductive technologies, reproductive endoscopic (minimally invasive) surgery, and Reproductive Telemedicine (Ontario Telemedicine Network). A compassionate practitioner and dedicated researcher, Dr. Baratz has presented his research at several national and international forums. Dr. Baratz has a special interest in all forms of third-party reproduction, including anonymous and known egg/sperm donation and surrogacy. He has provided consultations on reproductive medicine matters for intended parents throughout Ontario, across Canada, and internationally.

Dr. Baratz is an active member of the College of Physicians & Surgeons of Ontario, the Royal College of Surgeons of Canada, the Society of Obstetricians & Gynecologists of Canada, the American College of Obstetricians & Gynecologists, the Canadian Fertility & Andrology Society, and the American Society of Reproductive Medicine. Dr. Baratz has been an Executive Board member for the Women’s College Hospital, Medical Staff Association, the Women’s College Hospital Alternate Funding Plan, and Chair of the Ontario Medical Association Reproductive Biology Section.

First Response Canada

Afynia Laboratories, a Canadian biotechnology company, is pleased to announce the availability of EndomiR, the first validated diagnostic blood test for endometriosis. Afynia is currently offering EndomiR to Canadian fertility clinics for patients with unexplained infertility and/or symptoms suggestive of endometriosis. EndomiR shortens the diagnostic pathway by providing physicians with actionable data to inform safe and effective treatment options.

This episode is sponsored by First Response Canada.